title: Evolution of insulin patents and market exclusivities in the USA.
authors.affiliation: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. Electronic address: jluo1@partners.org.
authors.forename: Jing
authors.initials: J
authors.lastname: Luo
authors.affiliation: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy; D015195:Drug Design; D016568:Drugs, Generic / Q000191:economics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use; D007328:Insulin / Q000191:economics* / Q000627:therapeutic use; D010330:Patents as Topic; D014481:United States
chemical_list: D016568:Drugs, Generic; D007004:Hypoglycemic Agents; D007328:Insulin